These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2656477)

  • 1. The use of liposomes as drug carriers in the immunotherapy of cancer.
    Fidler IJ
    Horiz Biochem Biophys; 1989; 9():213-48. PubMed ID: 2656477
    [No Abstract]   [Full Text] [Related]  

  • 2. A new type of liposome for electrochemical treatment of cancer: the lipogelosomes.
    Hauton JC; Charbonnier M; Cara L; Salles JP
    Eur J Surg Suppl; 1994; (574):117-9. PubMed ID: 7531013
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemistry and biology of immunotargeted liposomes.
    Weiner AL
    Targeted Diagn Ther; 1990; 3():305-36. PubMed ID: 2131015
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug targeting by surface cationization.
    Blau S; Jubeh TT; Haupt SM; Rubinstein A
    Crit Rev Ther Drug Carrier Syst; 2000; 17(5):425-65. PubMed ID: 11108156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug delivery in cancer using liposomes.
    Dass CR
    Methods Mol Biol; 2008; 437():177-82. PubMed ID: 18369969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligonucleotide delivery to tumours using macromolecular carriers.
    Dass CR
    Biotechnol Appl Biochem; 2004 Oct; 40(Pt 2):113-22. PubMed ID: 15070400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective induction of anti-tumor immune responses with oligomannose-coated liposome targeting to intraperitoneal phagocytic cells.
    Ikehara Y; Shiuchi N; Kabata-Ikehara S; Nakanishi H; Yokoyama N; Takagi H; Nagata T; Koide Y; Kuzushima K; Takahashi T; Tsujimura K; Kojima N
    Cancer Lett; 2008 Feb; 260(1-2):137-45. PubMed ID: 18077084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent advances in liposomes and nanoparticles as drug carriers for drug delivery].
    Liu Y; Lü WL; Zhang Q
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Aug; 28(4):583-9. PubMed ID: 16995319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposome-encapsulated macrophage activation agents and active non-specific immunotherapy of neoplastic disease.
    Poste G; Kirsh R
    Prog Clin Biol Res; 1982; 102 pt A():309-19. PubMed ID: 7167443
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and liposome insertion of a new poly(carboranylalkylthio)porphyrazine to improve potentiality in multiple-approach cancer therapy.
    Ristori S; Salvati A; Martini G; Spalla O; Pietrangeli D; Rosa A; Ricciardi G
    J Am Chem Soc; 2007 Mar; 129(10):2728-9. PubMed ID: 17298062
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunoliposomes for cancer treatment.
    Park JW; Hong K; Kirpotin DB; Papahadjopoulos D; Benz CC
    Adv Pharmacol; 1997; 40():399-435. PubMed ID: 9217932
    [No Abstract]   [Full Text] [Related]  

  • 12. Specific active immunotherapy with butanol-extracted, tumor-associated antigens incorporated into liposomes.
    Steele G; Ravikumar T; Ross D; King V; Wilson RE; Dodson T
    Surgery; 1984 Aug; 96(2):352-9. PubMed ID: 6463864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomes as drug carriers in the therapy of infectious diseases.
    Juliano RL
    Horiz Biochem Biophys; 1989; 9():249-79. PubMed ID: 2656478
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluorescence microscopy to follow the targeting of liposomes and micelles to cells and their intracellular fate.
    Torchilin VP
    Adv Drug Deliv Rev; 2005 Jan; 57(1):95-109. PubMed ID: 15518923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein-coated and polysaccharide-coated liposomes as drug carriers.
    Sunamoto J; Iwamoto K
    Crit Rev Ther Drug Carrier Syst; 1986; 2(2):117-36. PubMed ID: 3518958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Targeting therapy for malignant brain tumors].
    Kochi M; Ushio Y
    Gan To Kagaku Ryoho; 1994 May; 21(6):738-42. PubMed ID: 8185328
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of serum lipoproteins on the pharmacokinetics and pharmacodynamics of lipophilic drugs and drug carriers.
    Wasan KM; Lopez-Berestein G
    Arch Med Res; 1993; 24(4):395-401. PubMed ID: 8118164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The liposomal formulation of doxorubicin.
    Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
    Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer-specific monoclonal antibody 5D4 significantly enhances the cytotoxicity of doxorubicin-loaded liposomes against target cells in vitro.
    Sawant RM; Cohen MB; Torchilin VP; Rokhlin OW
    J Drug Target; 2008 Aug; 16(7):601-4. PubMed ID: 18686131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antitumor effect of IL-2 entrapped in liposomes on rat hepatoma, AH-66].
    Konno H; Toriyama H; Aoki K; Baba S; Sakaguchi S; Yamashita A; Tadakuma T
    Gan To Kagaku Ryoho; 1989 Jan; 16(1):53-8. PubMed ID: 2783545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.